Charles Schwab’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.83M | Buy |
1,106,260
+41,402
| +4% | +$143K | ﹤0.01% | 2445 |
|
|
2025
Q1 | $2.79M | Buy |
1,064,858
+54,051
| +5% | +$142K | ﹤0.01% | 2511 |
|
|
2024
Q4 | $4.16M | Sell |
1,010,807
-24,982
| -2% | -$103K | ﹤0.01% | 2418 |
|
|
2024
Q3 | $7.33M | Buy |
1,035,789
+214,398
| +26% | +$1.52M | ﹤0.01% | 2182 |
|
|
2024
Q2 | $5.36M | Sell |
821,391
-90,766
| -10% | -$592K | ﹤0.01% | 2334 |
|
|
2024
Q1 | $7.57M | Buy |
912,157
+34,344
| +4% | +$285K | ﹤0.01% | 2123 |
|
|
2023
Q4 | $9.66M | Buy |
877,813
+163,008
| +23% | +$1.79M | ﹤0.01% | 2001 |
|
|
2023
Q3 | $6.01M | Buy |
714,805
+42,411
| +6% | +$357K | ﹤0.01% | 2172 |
|
|
2023
Q2 | $8.45M | Buy |
672,394
+18,512
| +3% | +$233K | ﹤0.01% | 1983 |
|
|
2023
Q1 | $10.8M | Sell |
653,882
-561
| -0.1% | -$9.24K | ﹤0.01% | 1838 |
|
|
2022
Q4 | $9.78M | Buy |
654,443
+35,476
| +6% | +$530K | ﹤0.01% | 1870 |
|
|
2022
Q3 | $13.8M | Buy |
618,967
+73,483
| +13% | +$1.64M | 0.01% | 1639 |
|
|
2022
Q2 | $9.14M | Buy |
545,484
+894
| +0.2% | +$15K | ﹤0.01% | 1880 |
|
|
2022
Q1 | $16.3M | Buy |
544,590
+16,572
| +3% | +$496K | ﹤0.01% | 1687 |
|
|
2021
Q4 | $16.2M | Buy |
528,018
+99,696
| +23% | +$3.06M | ﹤0.01% | 1736 |
|
|
2021
Q3 | $13.5M | Buy |
428,322
+205,352
| +92% | +$6.47M | ﹤0.01% | 1836 |
|
|
2021
Q2 | $8.16M | Buy |
222,970
+28,779
| +15% | +$1.05M | ﹤0.01% | 2105 |
|
|
2021
Q1 | $6.71M | Buy |
194,191
+34,628
| +22% | +$1.2M | ﹤0.01% | 2154 |
|
|
2020
Q4 | $6.63M | Buy |
159,563
+4,520
| +3% | +$188K | ﹤0.01% | 2082 |
|
|
2020
Q3 | $6.6M | Buy |
+155,043
| New | +$6.6M | ﹤0.01% | 1935 |
|